ArticleBMC chemistry2025

Mechanism-informed identification of FDA-approved topoisomerase inhibitors disrupting SARS-CoV-2 nucleocapsid-RNA interactions.

Da-Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.